Nadia Altomare
Director/Board Member bei Savran Technologies, Inc.
Vermögen: 166 530 $ am 31.03.2024
Profil
Nadia F.
Altomare is currently the Director at Savran Technologies, Inc. and Patient Rights Advocate, Inc. She was previously the CEO & Director at Abcodia Ltd., Vice President & General Manager at Revvity, Inc., VP & General Manager-Global DNA Analysis at Thermo Fisher Scientific, Inc., and is set to be the Chief Commercial Officer at Sera Prognostics, Inc. until 2023.
Altomare holds an undergraduate degree from Stony Brook University and an MBA from Northeastern University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2023 | 18 300 ( 0,06% ) | 166 530 $ | 31.03.2024 |
Aktive Positionen von Nadia Altomare
| Unternehmen | Position | Beginn |
|---|---|---|
Savran Technologies, Inc.
 Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| Patient Rights Advocate, Inc. | Director/Board Member | - |
Ehemalige bekannte Positionen von Nadia Altomare
| Unternehmen | Position | Ende |
|---|---|---|
| SERA PROGNOSTICS, INC. | Corporate Officer/Principal | 09.06.2023 |
Abcodia Ltd.
 Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Chief Executive Officer | 01.05.2017 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01.01.2014 |
| REVVITY, INC. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Nadia Altomare
| Stony Brook University | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REVVITY, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| SERA PROGNOSTICS, INC. | Health Services |
| Private Unternehmen | 3 |
|---|---|
Abcodia Ltd.
Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Health Technology |
Savran Technologies, Inc.
Savran Technologies, Inc. BiotechnologyHealth Technology Savran Technologies, Inc. provide and develops a technology to isolate ultra-rare cells from blood. The company was founded by Cagri Savran in 2018 and is headquartered in Cambridge, MA. | Health Technology |
| Patient Rights Advocate, Inc. |
